silybin has been researched along with Experimental Hepatoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brandon-Warner, E; McKillop, IH; Schrum, LW; Sugg, JA | 1 |
| Bour, G; Bousserouel, S; Gossé, F; Kauntz, H; Marescaux, J; Raul, F | 1 |
2 other study(ies) available for silybin and Experimental Hepatoma
| Article | Year |
|---|---|
Silibinin inhibits ethanol metabolism and ethanol-dependent cell proliferation in an in vitro model of hepatocellular carcinoma.
Topics: Animals; Antioxidants; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Cytochrome P-450 CYP2E1; Ethanol; Lipid Peroxidation; Liver Neoplasms, Experimental; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Rats; Reactive Oxygen Species; Silybin; Silymarin | 2010 |
Silibinin inhibits tumor growth in a murine orthotopic hepatocarcinoma model and activates the TRAIL apoptotic signaling pathway.
Topics: Animals; Apoptosis; Cell Growth Processes; Cell Line, Tumor; Disease Models, Animal; Gene Expression Regulation, Neoplastic; Liver Neoplasms, Experimental; Male; Mice; Mice, Inbred C57BL; Receptors, TNF-Related Apoptosis-Inducing Ligand; Signal Transduction; Silybin; Silymarin; TNF-Related Apoptosis-Inducing Ligand | 2012 |